Octane, a strategic partner for emerging companies, today announced details of this year’s Octane 2023 Medical Innovation Forum. The two-day event is slated to take place at the Irvine Marriott in Irvine, California, on October 25-26, 2023. The forum will feature some of the medical technology sector’s most visionary speakers, granting access to invaluable educational opportunities, showcasing cutting-edge technological advances, and providing a prime networking platform to explore synergies and foster enduring partnerships among industry professionals. “Southern California is one of the country’s most dynamic and promising markets, and Octane aims to create more than 55,000 technology jobs by 2030 here,” said Octane CEO Bill Carpou. “The Medical Innovation Forum is a key component of this larger vision, especially pertinent given the pandemic, rising health costs and aging demographics in many parts of the world. This event puts Southern California on the map and showcases the region’s innovation potential. We hope to play our part in paving the way for more technological development, increased investments and deeper regional networks.”
To view the full press release, visit https://ibn.fm/qdcRs
About Octane
Octane is building the SoCal of tomorrow by connecting people, resources and capital to fuel technology growth in Southern California. Its members represent technology executive leaders, entrepreneurs, investors, venture capitalists, academicians and strategic advisors, all working together to fuel innovation in the OC. The organization has helped more than 1,573 companies via the LaunchPad SBDC accelerator. LaunchPad companies have received more than $5.2 billion in investment and equity exits. Octane annually welcomes more than 7,000 people to its programs and events. More than 2,000 business leaders throughout the region are Octane members. For more information, visit www.OctaneOC.org.
About BioMedWire
BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed)and Life Sciences sectors. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.
BMW is where breaking news, insightful content and actionable information converge.
To receive SMS alerts from BioMedWire, “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer
BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is powered by IBN